Clik here to view.
GlaxoSmithKline Pushed Diabetes Drug Avandia Despite Heart Attack Risks
One of the key risks for people with diabetes is heart attacks. The diabetes medication Avandia is known to cause heart attacks, which doubles the risks for diabetic patients. Insurance analysts say...
View ArticleWill Diabetes Drug Avandia Be Recalled?
The diabetes drug Avandia seems to be on the high wire. According to the Wall Street Journal the FDA is planning to shut down a study between the side effects of Avandia and Actos, another […] The post...
View ArticleAvandia studies place medication on edge of recall
Heart Risk from Popular Diabetes Medication The diabetes medication Avandia by GlaxoSmithKline has been the subject of two studies that were released Monday. These studies show that the use of Avandia...
View ArticleAvandia panel says diabetes drug should stay on market
Shocker from the FDA advisory panel: it voted Avandia should stay on the market despite the fact it increases the risk for heart attack. Total vote count: 20 for continued marketing with restrictions...
View ArticleTakeda Hid Actos Bladder Cancer Risks, Whistleblower Case Says
The U.S. District Judge F. Dennis Saylor issued an order to unseal a whistleblower case by a former Takeda Pharmaceuticals medical reviewer involving the failure to report bladder cancer and Congestive...
View Article
